Multiple Sclerosis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

STUDY VISITS

MS PATIENTS

NEUROLOGISTS

Participating Sites

CorEvitas has MS clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.

Outcome measures in the CorEvitas Multiple Sclerosis Registry.

Among the variables we collect, some of the key outcome measures to inform your MS research include:

Clinician Reported Outcomes

Patient Reported Outcomes

MS Disability Score: Patient Determined Disease Steps (PDDS)
Depression Outcome: Patient Health Questionnaire-2 (PHQ-2)
Multiple Sclerosis Impact Scale (MSIS-29)
Work Productivity and Activity Impairment (WPAI)
Fatigue (shortened, modified Fatigue Impact Scale)
Patient Global Impression of Change (PGIC)
Pain Numerical Rating Scale

Registry Scientific Advisors

Aaron E. Miller, MD, FAAN

Professor of Neurology, Icahn School of Medicine at Mount Sinai | Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis | Vice-Chair for Education, Department of Neurology

Daniel J. Kantor, MD, FAAN, FANA

President Emeritus, Florida Society of Neurology | Founding president, Medical Partnership 4 MS (MP4MS) | Health care advisory committee member: Multiple Sclerosis Foundation (MSF), Multiple Sclerosis Association of America (MSAA), MS Views and News (MSVN) | Chief medical correspondent, MS World

Subscribe to our newsletter